glp 1 ilaçları İnsülin yerine GLP-1 kullanan diyabet hastalarının kanser riskinin daha düşük olduğu, araştırmayla ortaya konuldu Yeni Nesil Zayıflama İlaçları: GLP-1

Psoriasis management has traditionally focused on controlling skin symptoms, but these findings emphasise the need to consider the wider health risks faced by patients

Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH (2004) One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes

you're also contributing to the 10% of our profits that we donate to veteran-focused charities in BUB's honor

We are not seeing an explosion of new research

Patients who stayed on GLP-1s for the full three years of the study saw the strongest protection: an 18% reduction in cardiovascular risk, or about four fewer major cardiac events per 100 people compared with those on a different diabetes medication